These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 2663609)
1. A multi-centre double-blind controlled trial of glucagon and insulin therapy for severe acute hepatitis. Oka H; Fujiwara K; Okita K; Ishii H; Sakuma A Gastroenterol Jpn; 1989 Jun; 24(3):332-6. PubMed ID: 2663609 [TBL] [Abstract][Full Text] [Related]
2. Reciprocal changes in serum albumin and alpha-fetoprotein levels in the recovery course of acute viral hepatitis stimulated by glucagon and insulin therapy: analysis of a double blind controlled trial. Fujiwara K; Ogata I; Oka H Gastroenterol Jpn; 1989 Apr; 24(2):143-8. PubMed ID: 2472994 [TBL] [Abstract][Full Text] [Related]
3. A randomized clinical trial of insulin and glucagon infusion for treatment of alcoholic hepatitis: progress report in 50 patients. Baker AL; Jaspan JB; Haines NW; Hatfield GE; Krager PS; Schneider JF Gastroenterology; 1981 Jun; 80(6):1410-4. PubMed ID: 7014349 [TBL] [Abstract][Full Text] [Related]
4. A prospective multicenter study of insulin and glucagon infusion therapy in acute alcoholic hepatitis. Fehér J; Cornides A; Romány A; Kárteszi M; Szalay L; Gógl A; Picazo J J Hepatol; 1987 Oct; 5(2):224-31. PubMed ID: 3320181 [TBL] [Abstract][Full Text] [Related]
5. Insulin and glucagon infusion in acute alcoholic hepatitis: a prospective randomized controlled trial. Bird G; Lau JY; Koskinas J; Wicks C; Williams R Hepatology; 1991 Dec; 14(6):1097-101. PubMed ID: 1959860 [TBL] [Abstract][Full Text] [Related]
6. (+)-Cyanidanol-3 in the treatment of acute viral hepatitis: a randomized controlled trial. Schomerus H; Wiedmann KH; Dölle W; Peerenboom H; Strohmeyer G; Balzer K; Goebell H; Dürr HK; Bode C; Blum AL Hepatology; 1984; 4(2):331-5. PubMed ID: 6368355 [TBL] [Abstract][Full Text] [Related]
7. Failure of insulin and glucagon infusion to stimulate liver regeneration in fulminant hepatic failure. Harrison PM; Hughes RD; Forbes A; Portmann B; Alexander GJ; Williams R J Hepatol; 1990 May; 10(3):332-6. PubMed ID: 2195108 [TBL] [Abstract][Full Text] [Related]
8. Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: a multicenter sequential trial. Trinchet JC; Balkau B; Poupon RE; Heintzmann F; Callard P; Gotheil C; Grange JD; Vetter D; Pauwels A; Labadie H Hepatology; 1992 Jan; 15(1):76-81. PubMed ID: 1727803 [TBL] [Abstract][Full Text] [Related]
9. A randomized double-blind trial of glucagon in treatment of first attack of severe acute pancreatitis without associated biliary disease. Kronborg O; Bülow S; Joergensen PM; Svendsen LB Am J Gastroenterol; 1980 May; 73(5):423-5. PubMed ID: 6998284 [TBL] [Abstract][Full Text] [Related]
10. Intrahepatic cholestasis in acute viral hepatitis: a double-blind trial with dihydroxydibutylether in comparison with placebo. Marchettini G; Corsini P; Massimini G Drugs Exp Clin Res; 1987; 13(1):51-6. PubMed ID: 3297594 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of the analogue of natural Schisandrin C (HpPro) in treatment of liver diseases: an experience in Indonesian patients. Akbar N; Tahir RA; Santoso WD; Soemarno ; Sumaryono ; Noer HM; Liu G Chin Med J (Engl); 1998 Mar; 111(3):248-51. PubMed ID: 10374427 [TBL] [Abstract][Full Text] [Related]
12. The effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide on acute viral hepatitis. Ayrosa-Galvão PA; Castro IO Ann N Y Acad Sci; 1977 Mar; 284():278-83. PubMed ID: 360902 [TBL] [Abstract][Full Text] [Related]
14. A double-blind clinical trial of kamalahar, an indigenous compound preparation, in acute viral hepatitis. Das DG Indian J Gastroenterol; 1993 Oct; 12(4):126-8. PubMed ID: 8270290 [TBL] [Abstract][Full Text] [Related]
15. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Carithers RL; Herlong HF; Diehl AM; Shaw EW; Combes B; Fallon HJ; Maddrey WC Ann Intern Med; 1989 May; 110(9):685-90. PubMed ID: 2648927 [TBL] [Abstract][Full Text] [Related]
16. Treatment of acute viral hepatitis with (+)-cyanidanol-3. Blum AL; Berthet P; Doelle W; Goebell H; Kortüm K; Pelloni S; Peter P; Poulsen H; Strohmeyer G; Tygstrup N Lancet; 1977 Dec; 2(8049):1153-5. PubMed ID: 73062 [TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide-1 infusion must be maintained for 24 h/day to obtain acceptable glycemia in type 2 diabetic patients who are poorly controlled on sulphonylurea treatment. Larsen J; Hylleberg B; Ng K; Damsbo P Diabetes Care; 2001 Aug; 24(8):1416-21. PubMed ID: 11473079 [TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of glucagon and insulin in therapy of fulminant hepatitis. Okita K; Matsuda S; Hanta T; Yasunaga M; Sanuki K; Takemoto T Gastroenterol Jpn; 1987 Oct; 22(5):607-13. PubMed ID: 3315819 [TBL] [Abstract][Full Text] [Related]
19. Ribavirin in acute viral hepatitis. Ajgaonkar VS; Mogre VM Indian J Gastroenterol; 1991 Jul; 10(3):90-1. PubMed ID: 1916970 [TBL] [Abstract][Full Text] [Related]
20. Liver regeneration in fulminant hepatitis as evaluated by serum transforming growth factor alpha levels. Tomiya T; Fujiwara K Hepatology; 1996 Feb; 23(2):253-7. PubMed ID: 8591849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]